Biochemical characterisation of human isolates of Blastocystis hominis

This study investigated biochemical differences among 11 human isolates of Blastocystis hominis, a common intestinal protozoan. Researchers used SDS-PAGE protein analysis and iso-enzyme electrophoresis to characterize isolates from nine patients with gastrointestinal symptoms and two asymptomatic individuals. SDS-PAGE revealed two protein variants, differentiated by the presence of a 40-kDa band and absence of a 35-kDa band in one variant. Iso-enzyme analysis, performed for the first time on B. hominis, identified two zymodemes (Z-I and Z-II) based on patterns of five enzymes: glucose phosphate isomerase, phosphoglucomutase, malic enzyme, 6-phosphogluconate dehydrogenase, and hexokinase. Zymodeme Z-I was found in three isolates from asymptomatic carriers and one patient with shigellosis-associated diarrhea. Zymodeme Z-II, subdivided into variants Z-IIa and Z-IIb, was found in eight symptomatic patients. The authors suggest these biochemical differences may relate to varying pathogenic potential, though mixed infections in study subjects complicated definitive conclusions about disease causation.

Key findings

• SDS-PAGE analysis revealed at least two protein variants among the 11 B. hominis isolates, with one isolate differing by presence of a 40-kDa band and absence of a 35-kDa band.
• Iso-enzyme analysis identified two zymodemes (Z-I and Z-II), with Z-I associated with asymptomatic carriers and Z-II predominantly with symptomatic patients.
• This was the first iso-enzyme analysis and second protein analysis demonstrating strain-level differences in B. hominis biochemistry.
• Zymodeme Z-II subdivided into two variants (Z-IIa and Z-IIb) based on phosphoglucomutase migration patterns, suggesting further heterogeneity among symptomatic isolates.
• Biochemical characterization provides a more nuanced classification system than previous methods for potentially distinguishing pathogenic from non-pathogenic B. hominis strains.